双胎输血综合征:开发、传播和实施核心结局指标集的研究方案
双胎输血综合征(TTTS)的文献报告结局各异,难以比较和合并数据,限制了研究对临床实践的指导价值。本方案拟通过系统综述识别既往报告的结局,采用国际多视角在线改良德尔菲法由利益相关者(含患者)达成共识,再经共识会议形成核心结局指标集,并确定其测量、传播与实施方式。
要点
- TTTS研究结局报告不一致,难以比较和合并数据,限制了研究指导临床实践的价值。
- 拟通过系统综述和在线改良德尔菲法,由多利益相关者(含患者)达成核心结局共识。
- 核心结局指标集将用于未来临床试验、系统综述和临床实践指南。
核心结论
- 开发、传播和实施TTTS核心结局指标集,将有助于提升研究质量及其在指导临床实践、改善患者护理、孕产妇结局、短期围产期结局和长期神经发育结局方面的有效应用。
研究设计与样本
- 已成立国际指导组监督核心结局指标集的开发,成员包括医疗专业人员、研究人员和患者。
- 计划开展系统综述以识别TTTS治疗后既往报告的结局。
- 采用国际多视角在线改良德尔菲法,邀请所有关键利益相关者参与,就核心结局达成共识。
- 指导组将召开共识会议讨论结果并形成核心结局指标集。
- 试验注册:COMET 921,2016年7月注册;PROSPERO CRD42016043999,2016年8月2日注册。
主要发现
- TTTS与围产期死亡和疾病风险增加相关。
- 已描述的TTTS治疗干预包括胎儿镜激光手术、羊水减量术、隔膜造口术、期待管理和终止妊娠。
- 过去十年中,胎儿镜激光手术已成为主要治疗方法。
- 迄今文献报告了许多不同的结局,使得难以比较结果或合并各研究数据。
临床怎么用
- 核心结局指标集确定后,下一步将确定其测量、传播和在 international 背景下实施的方式。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Twin-Twin Transfusion Syndrome (TTTS) is associated with an increased risk of perinatal mortality and morbidity. Several treatment interventions have been described for TTTS, including fetoscopic laser surgery, amnioreduction, septostomy, expectant management, and pregnancy termination. Over the last decade, fetoscopic laser surgery has become the primary treatment. The literature to date reports on many different outcomes, making it difficult to compare results or combine data from individual studies, limiting the value of research to guide clinical practice. With the advent and ongoing development of new therapeutic techniques, this is more important than ever. The development and use of a core outcome set has been proposed to address these issues, prioritising outcomes important to the key stakeholders, including patients. We aim to produce, disseminate, and implement a core outcome set for TTTS. METHODS: An international steering group has been established to oversee the development of this core outcome set. This group includes healthcare professionals, researchers and patients. A systematic review is planned to identify previously reported outcomes following treatment for TTTS. Following completion, the identified outcomes will be evaluated by stakeholders using an international, multi-perspective online modified Delphi method to build consensus on core outcomes. This method encourages the participants towards consensus 'core' outcomes. All key stakeholders will be invited to participate. The steering group will then hold a consensus meeting to discuss results and form a core outcome set to be introduced and measured. Once core outcomes have been agreed, the next step will be to determine how they should be measured, disseminated, and implemented within an international context. DISCUSSION: The development, dissemination, and implementation of a core outcome set in TTTS will enable its use in future clinical trials, systematic reviews and clinical practice guidelines. This is likely to advance the quality of research studies and their effective use in order to guide clinical practice and improve patient care, maternal, short-term perinatal outcomes and long-term neurodevelopmental outcomes. TRIAL REGISTRATION: Core Outcome Measures in Effectiveness Trials (COMET), 921 Registered on July 2016. International Prospective Register of Systematic Reviews (PROSPERO), CRD42016043999 . Registered on 2 August 2016.
引用
- Khalil A, Perry H, Duffy J, et al. Twin-Twin Transfusion Syndrome: study protocol for developing, disseminating, and implementing a core outcome set. Trials. 2017. PMID: 28709445. doi:10.1186/s13063-017-2042-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。